- Home
- SEAT vs CVRX Comparison
SEAT vs CVRX Comparison
Compare SEAT & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEAT
- CVRX
- Stock Information
- Founded
- SEAT 2001
- CVRX 2000
- Country
- SEAT United States
- CVRX United States
- Employees
- SEAT N/A
- CVRX N/A
- Industry
- SEAT Industrial Machinery/Components
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SEAT Industrials
- CVRX Health Care
- Exchange
- SEAT Nasdaq
- CVRX Nasdaq
- Market Cap
- SEAT 366.2M
- CVRX 419.8M
- IPO Year
- SEAT N/A
- CVRX 2021
- Fundamental
- Price
- SEAT $2.31
- CVRX $6.25
- Analyst Decision
- SEAT Buy
- CVRX Strong Buy
- Analyst Count
- SEAT 11
- CVRX 7
- Target Price
- SEAT $5.58
- CVRX $16.83
- AVG Volume (30 Days)
- SEAT 1.9M
- CVRX 516.2K
- Earning Date
- SEAT 05-06-2025
- CVRX 05-08-2025
- Dividend Yield
- SEAT N/A
- CVRX N/A
- EPS Growth
- SEAT N/A
- CVRX N/A
- EPS
- SEAT 0.06
- CVRX N/A
- Revenue
- SEAT $775,586,000.00
- CVRX $51,292,000.00
- Revenue This Year
- SEAT N/A
- CVRX $22.17
- Revenue Next Year
- SEAT $5.80
- CVRX $24.02
- P/E Ratio
- SEAT $41.05
- CVRX N/A
- Revenue Growth
- SEAT 8.80
- CVRX 30.53
- 52 Week Low
- SEAT $2.36
- CVRX $5.87
- 52 Week High
- SEAT $6.09
- CVRX $18.55
- Technical
- Relative Strength Index (RSI)
- SEAT 32.58
- CVRX 25.78
- Support Level
- SEAT $2.36
- CVRX $5.91
- Resistance Level
- SEAT $2.90
- CVRX $6.71
- Average True Range (ATR)
- SEAT 0.23
- CVRX 0.84
- MACD
- SEAT 0.01
- CVRX -0.43
- Stochastic Oscillator
- SEAT 0.66
- CVRX 5.28
About SEAT Vivid Seats Inc.
Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.